Ditchcarbon
  • Contact
  1. Organizations
  2. Immuno Concepts N.A. Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

Immuno Concepts N.A. Ltd.

Company website

Immuno Concepts N.A. Ltd., a leading name in the immunology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1985, the company has established itself as a pioneer in the development of innovative diagnostic solutions for autoimmune diseases. Specialising in high-quality immunological assays, Immuno Concepts offers a unique range of products, including enzyme-linked immunosorbent assays (ELISAs) and indirect immunofluorescence assays (IFA). Their commitment to precision and reliability has positioned them as a trusted partner for laboratories worldwide. With a strong focus on research and development, Immuno Concepts continues to achieve significant milestones, enhancing its market position and contributing to advancements in autoimmune diagnostics.

DitchCarbon Score

How does Immuno Concepts N.A. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Immuno Concepts N.A. Ltd.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.

32%

Let us know if this data was useful to you

Immuno Concepts N.A. Ltd.'s reported carbon emissions

In 2024, Immuno Concepts N.A. Ltd. reported total carbon emissions of approximately 384,850 kg CO2e. This figure includes Scope 1 emissions of about 98,800 kg CO2e, Scope 2 emissions of approximately 9,080 kg CO2e, and significant Scope 3 emissions totalling around 276,967 kg CO2e. Within the Scope 3 category, employee commute accounted for about 12,500 kg CO2e, while purchased goods and services contributed a minimal 11 kg CO2e. Upstream transportation and distribution were responsible for approximately 146,470 kg CO2e, and downstream transportation and distribution added about 18,750 kg CO2e. Currently, Immuno Concepts N.A. Ltd. has not established any specific reduction targets or initiatives, nor do they participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). The absence of formal commitments indicates a potential area for future development in their climate strategy. The company does not inherit emissions data from any parent organisation, ensuring that their reported figures are solely reflective of their own operations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Immuno Concepts N.A. Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Immuno Concepts N.A. Ltd. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Immuno Concepts N.A. Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Diasorin

IT
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Hologic

US
•
Research and development services (73)
Updated 1 day ago

Thermo Fisher Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 18 hours ago

F. Hoffmann-La Roche AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Inova Diagnostics Limited

GB
•
Other business services (74)
Updated about 2 months ago

Meridian Bioscience, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 28 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy